Skip to main content
MESA LABORATORIES INC /CO/ logo

MESA LABORATORIES INC /CO/ — Investor Relations & Filings

Ticker · MLAB ISIN · US59064R1095 LEI · 549300ZCG738WLX8ZW79 US Manufacturing
Open in API
Filings indexed 1,015 across all filing types
Latest filing 2017-03-20 Board/Management Inform…
Country US United States of America
Listing US MLAB

About MESA LABORATORIES INC /CO/

https://mesalabs.com

Mesa Laboratories, Inc. designs, manufactures, and markets quality control products and services for regulated industries. The company specializes in life sciences tools and critical quality control solutions, including analytical instruments and related consumables. Its products are utilized primarily in the pharmaceutical, healthcare, and medical device sectors to ensure product safety, integrity, and performance. Mesa Laboratories focuses on applying technical expertise and technological innovation to help customers monitor and maintain high standards, supporting compliance with various regulatory requirements and international standards for quality management, testing, and calibration.

Recent filings

Filing Released Lang Actions
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 20, 2017, by Mesa Laboratories, Inc. The content specifically announces the appointment of a new Vice President and Chief Operating Officer, Gary Owens, including details about his background, compensation, and stock awards. This type of announcement relates to changes in the company's senior management. There are no financial statements, earnings data, or other report content present. The document is not a report itself but a current report filing about management changes. Therefore, the appropriate classification is 'Board/Management Information' (MANG). The document length is 3658 characters, which is consistent with a typical 8-K management change announcement. Confidence is high due to the clear and specific content about management appointment.
2017-03-20 English
FORM 8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated March 1, 2017, for Mesa Laboratories, Inc. It reports the entry into a material definitive agreement, specifically a new credit facility including a revolving line of credit and term loan, and the termination of a previous credit facility. The content focuses on financing arrangements, interest rates, repayment terms, and related fees. There are no financial statements or earnings data presented, nor is this a full annual or quarterly report. The primary subject is an update on the company's financing activities and capital structure changes. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is over 5,000 characters and contains substantive details about the financing agreement, not just an announcement or certification, supporting a high confidence classification.
2017-03-01 English
PRIMARY DOCUMENT
Director's Dealing
2017-02-23 English
PRIMARY DOCUMENT
Director's Dealing
2017-02-21 English
PRIMARY DOCUMENT
Director's Dealing
2017-02-21 English
PRIMARY DOCUMENT
Director's Dealing
2017-02-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.